April 8, 2014 12:06 UTC

Research and Markets: Singapore Clinical Trial Market Analysis 2014

DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/2x4wkk/singapore) has announced the addition of the "Singapore Clinical Trial Market Analysis" report to their offering.

Singapore has off late come to become the nucleus of clinical research activities in the Asia-Pacific region. The country is a natural hub for manufacturers and clinicians. It also possesses one of the best healthcare infrastructure networks in the entire region. Singapore is the third largest market in Asia for conducting clinical trials. The national government has been extremely supportive in developing clinical research activities and maintaining high immunization rates.

The Singapore government in recent years has invested approximately USD1.1 billion into vaccine, translational and biomarker research. Additionally, the stringent intellectual-property laws and good clinical practice (GCP) guidelines is a significant source of security and assurance to the clients in the pharmaceuticals industry. Thus, the country is seen to have a great potential to capture the growth of the clinical trials industry not merely due to its strategic location, but also owing to its reputation of having a strong regulation in the biotech and pharmaceutical markets.

It has been estimated that during the period 2010-2013, more than 200 Clinical Trial Certificates were issued annually. A major proportion of these studies would be in the Phase 1 to 3 stage of drug development. Some of the most important therapeutic areas which would be focused in these trials would include oncology, clinical pharmacology, gastroenterology/ hepatology and cardiology. These areas represent the niche fields where Singapore has not yet completely built its medical expertise. The Singapore Good Clinical Practice (GCP) Guidelines were set up by the Ministry of Health in 1998. These guidelines ensure patient safety and the integrity of the resulting data.

Key Topics Covered:

1. Singapore Clinical Trial Market Overview

2. Disease Prevalence in Singapore

3. Patient Recruitment & Cost Analysis

4. Regulatory Framework to Conduct Clinical Trial

5. Competitive Landscape

Companies Mentioned

  • CPR Pharma Services
  • Clinical Research Unit - Tan Tock Seng Hospital
  • CON Clinical Research
  • Pacific Clinical Research
  • Chiltern
  • Department of Clinical Research - Singapore General Hospital
  • PPD
  • Singapore Clinical Research Institute

Visit http://www.researchandmarkets.com/research/2x4wkk/singapore


Research and Markets
Laura Wood, Senior Manager.
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector: Healthcare and Medical Devices

Source: Research and Markets